PT90584A - Processo de preparacao de agentes diureticos de glutaramidas enantiomericas - Google Patents

Processo de preparacao de agentes diureticos de glutaramidas enantiomericas

Info

Publication number
PT90584A
PT90584A PT90584A PT9058489A PT90584A PT 90584 A PT90584 A PT 90584A PT 90584 A PT90584 A PT 90584A PT 9058489 A PT9058489 A PT 9058489A PT 90584 A PT90584 A PT 90584A
Authority
PT
Portugal
Prior art keywords
enantiomeric
preparation
glutaramides
dental agents
dental
Prior art date
Application number
PT90584A
Other languages
English (en)
Other versions
PT90584B (pt
Inventor
John Christopher Danilewicz
Michael Trevelyan Williams
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of PT90584A publication Critical patent/PT90584A/pt
Publication of PT90584B publication Critical patent/PT90584B/pt

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C235/00—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms
    • C07C235/40—Carboxylic acid amides, the carbon skeleton of the acid part being further substituted by oxygen atoms having carbon atoms of carboxamide groups bound to carbon atoms of rings other than six-membered aromatic rings and singly-bound oxygen atoms bound to the same carbon skeleton
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C233/00—Carboxylic acid amides
    • C07C233/01—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms
    • C07C233/16—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms
    • C07C233/17—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom
    • C07C233/18—Carboxylic acid amides having carbon atoms of carboxamide groups bound to hydrogen atoms or to acyclic carbon atoms having the nitrogen atom of at least one of the carboxamide groups bound to a carbon atom of a hydrocarbon radical substituted by singly-bound oxygen atoms with the substituted hydrocarbon radical bound to the nitrogen atom of the carboxamide group by an acyclic carbon atom having the carbon atom of the carboxamide group bound to a hydrogen atom or to a carbon atom of an acyclic saturated carbon skeleton
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/06—Systems containing only non-condensed rings with a five-membered ring
    • C07C2601/08—Systems containing only non-condensed rings with a five-membered ring the ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2602/00—Systems containing two condensed rings
    • C07C2602/02—Systems containing two condensed rings the rings having only two atoms in common
    • C07C2602/04—One of the condensed rings being a six-membered aromatic ring
    • C07C2602/08—One of the condensed rings being a six-membered aromatic ring the other ring being five-membered, e.g. indane

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Steroid Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Detergent Compositions (AREA)
  • Cosmetics (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Hydrogenated Pyridines (AREA)
PT90584A 1988-05-19 1989-05-17 Processo de preparacao de agentes diureticos de glutaramidas enantiomericas PT90584B (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB888811873A GB8811873D0 (en) 1988-05-19 1988-05-19 Therapeutic agents

Publications (2)

Publication Number Publication Date
PT90584A true PT90584A (pt) 1989-11-30
PT90584B PT90584B (pt) 1994-09-30

Family

ID=10637176

Family Applications (1)

Application Number Title Priority Date Filing Date
PT90584A PT90584B (pt) 1988-05-19 1989-05-17 Processo de preparacao de agentes diureticos de glutaramidas enantiomericas

Country Status (29)

Country Link
EP (1) EP0342850B1 (pt)
JP (1) JPH072699B2 (pt)
KR (1) KR920000561B1 (pt)
CN (1) CN1015361B (pt)
AT (1) ATE76399T1 (pt)
AU (1) AU602813B2 (pt)
CA (1) CA1331197C (pt)
CS (1) CS274502B2 (pt)
DD (1) DD283772A5 (pt)
DE (1) DE68901582D1 (pt)
DK (1) DK172032B1 (pt)
EG (1) EG19007A (pt)
ES (1) ES2037418T3 (pt)
FI (1) FI93541C (pt)
GB (1) GB8811873D0 (pt)
GR (1) GR3004968T3 (pt)
HU (1) HU205067B (pt)
IE (1) IE60724B1 (pt)
IL (1) IL90267A (pt)
MX (1) MX16067A (pt)
MY (1) MY104735A (pt)
NO (1) NO173647C (pt)
NZ (1) NZ229186A (pt)
PH (1) PH26740A (pt)
PL (1) PL154813B1 (pt)
PT (1) PT90584B (pt)
SU (1) SU1766251A3 (pt)
YU (1) YU47973B (pt)
ZA (1) ZA893696B (pt)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8812597D0 (en) * 1988-05-27 1988-06-29 Pfizer Ltd Therapeutic agents
GB8820844D0 (en) * 1988-09-05 1988-10-05 Pfizer Ltd Therapeutic agents
GB9000725D0 (en) * 1990-01-12 1990-03-14 Pfizer Ltd Therapeutic agents
DE69300826T2 (de) * 1993-09-22 1996-04-18 Pfizer Res & Dev Hydrierung.
US7468390B2 (en) 2002-01-17 2008-12-23 Novartis Ag Methods of treatment and pharmaceutical composition
AR057882A1 (es) 2005-11-09 2007-12-26 Novartis Ag Compuestos de accion doble de bloqueadores del receptor de angiotensina e inhibidores de endopeptidasa neutra
US8993631B2 (en) * 2010-11-16 2015-03-31 Novartis Ag Method of treating contrast-induced nephropathy
MA37850A1 (fr) 2012-08-24 2018-07-31 Novartis Ag Inhibiteurs de nep pour le traitement de maladies caractérisées par un agrandissement atrial ou une remodélisation atriale
WO2017033128A1 (en) 2015-08-25 2017-03-02 Novartis Ag Biphenyl-substitued 4-amino-butyric acid derivatives and their use in the synthesis of nep inhibitors
WO2017072636A1 (en) 2015-10-29 2017-05-04 Cadila Healthcare Limited Pharmaceutical synergistic combination

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR880007441A (ko) * 1986-12-11 1988-08-27 알렌 제이.스피겔 스피로-치환된 글루타르아미드 이뇨제

Also Published As

Publication number Publication date
SU1766251A3 (ru) 1992-09-30
ES2037418T3 (es) 1993-06-16
IE60724B1 (en) 1994-08-10
EP0342850A1 (en) 1989-11-23
YU47973B (sh) 1996-08-13
MX16067A (es) 1993-10-01
CN1015361B (zh) 1992-02-05
DD283772A5 (de) 1990-10-24
FI93541B (fi) 1995-01-13
IL90267A0 (en) 1989-12-15
CN1037704A (zh) 1989-12-06
NO892002D0 (no) 1989-05-18
CA1331197C (en) 1994-08-02
YU102289A (en) 1991-06-30
JPH072699B2 (ja) 1995-01-18
NO173647B (no) 1993-10-04
HUT53596A (en) 1990-11-28
ZA893696B (en) 1990-12-28
PH26740A (en) 1992-09-28
CS296589A2 (en) 1990-09-12
JPH0222256A (ja) 1990-01-25
KR900017993A (ko) 1990-12-20
NO173647C (no) 1994-01-12
EG19007A (en) 1994-11-30
NZ229186A (en) 1990-10-26
DK172032B1 (da) 1997-09-22
PL154813B1 (en) 1991-09-30
AU602813B2 (en) 1990-10-25
DK240889D0 (da) 1989-05-18
FI892386A (fi) 1989-11-20
DE68901582D1 (de) 1992-06-25
FI892386A0 (fi) 1989-05-18
CS274502B2 (en) 1991-04-11
AU3490489A (en) 1989-11-23
IL90267A (en) 1993-08-18
HU205067B (en) 1992-03-30
GB8811873D0 (en) 1988-06-22
FI93541C (fi) 1995-04-25
MY104735A (en) 1994-05-31
PL279491A1 (en) 1989-11-27
PT90584B (pt) 1994-09-30
NO892002L (no) 1989-11-20
ATE76399T1 (de) 1992-06-15
GR3004968T3 (pt) 1993-04-28
KR920000561B1 (ko) 1992-01-16
IE891613L (en) 1989-11-19
DK240889A (da) 1989-11-20
EP0342850B1 (en) 1992-05-20

Similar Documents

Publication Publication Date Title
GR3024255T3 (en) Benzo-fused lactams
FR2707087B1 (fr) Nouveau procédé de préparation de l'ergothionéine.
PT90584A (pt) Processo de preparacao de agentes diureticos de glutaramidas enantiomericas
BR9404776A (pt) Processo para a preparação de 2,2-difluorceteno silil acetais e processo para a preparação de ésteres de ácido alfa,alfa-diflúor-beta-sililóxi-1,3-dioxolano-4-propanóico
OA07984A (fr) Procédé stéréocontrolé de préparation d'acetoxyazetidione.
FR2693473B1 (fr) Procédé de préparation enzymatique d'hydrolysats de matières protéiques.
ES509782A0 (es) Un procedimiento para la preparacion de nuevos bis-esteres de metanodiol y etanodiol.
PT92270A (pt) Processo para a preparacao de solvatos de um antibiotico beta-lactamico
FI890678A0 (fi) Analogiamenetelmä terapeuttisesti käyttökelpoisten 1,3-dioksaanialkeenihappojohdannaisten valmistamiseksi
PT80359A (en) (6,11-dihydro-11-oxodibenz<b,e>oxepinyl)pentanoic acids and derivatives a process and intermediates for their preparation and their use as medicaments
FR2611974B1 (fr) Composition de revetement des electrodes d'un parafoudre
PT83567B (pt) Novo processo de preparacao de derivados da 2,6-piperidindiona
DE3887174D1 (de) Verfahren zur Herstellung von 2,3-Dihydro-1H-imidazolylalkoxyinden-Derivaten und ihren pharmazeutisch annehmbaren Salzen, und Zwischenprodukte hierfür.
ATE144257T1 (de) Tetrahydro-4-phenylimino-3-thiophenessigsäuren
DE58909563D1 (de) 3-Anilino-2-hydroxycarbonyl-4-thiophenessigsäuren

Legal Events

Date Code Title Description
FG3A Patent granted, date of granting

Effective date: 19940315

MM3A Annulment or lapse

Free format text: LAPSE DUE TO NON-PAYMENT OF FEES

Effective date: 19990930